Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...

The cornea, which is the clear, transparent outer layer at the front of the eye, can get severely damaged during accidents ...

Northwestern Medicine investigators have developed first-of-its-kind eyedrops that use synthetic nanoparticles to help the ...

Scientists have developed eyedrops that can reverse inflammation and repair corneal stem cell damage in a mouse model of ...

NCP is a condition that causes severe pain and sensitivity of the eyes, face, or head. The exact cause is unknown but is ...

Living-related conjunctival limbal allograft should be first-line therapy for limbal stem cell deficiency, Edward J. Holland, ...

OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod ...

But other parts of the eye might benefit more from cell therapies: the cornea, the clear covering that lets light in, is maintained by a pool of stem cells and constantly being rebuilt.

and the immune response of resident corneal cells. Corneal disease in vernal keratoconjunctivitis and atopic keratoconjunctivitis currently requires aggressive treatment with topical steroids.

Urcosimod phase 2 trial treating Neuropathic Corneal Pain ("NCP”) patients was initiated in October 2024 and designed as a ...